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Results: Nowadays the cystatinsuper family is known to comprise about 30 members.The 
members o f  cystatin family II -cystatin C, D, S, SA, SN, E/M and F, are found in body fluids.Their 
involvement in inflammatory processes, cancerogenesis and metastasis, bone remodeling and in other 
processes has been undoubtedly demonstrated.Cystatins S, SN and SA were found in submandibular 
and sublingual glands, while cystatin D was detected only in parotid glands.Salivary cystatinsS, SN, 
SAand D contribute to the maintenance o f  the oral health through the inhibition o f  endo- and exogen 
cysteine proteases, antimicrobial and antiviral protection and regulation o f  hard tooth tissue remodeling.
Conclusions: Studies o f  major significance attest the clinical utility o f  cystatins’ assay 
(cystatin C) for the diagnosis o f  some diseases (for ex. renal failure). In addition, cystatin C, among 
other cystatins, decreases the formation o f  osteoclasts by interfering at a late stage o f  pre-osteoclast 
differentiation.Cystatin D is produced by the parotid gland and is secreted through blood serum to 
the whole body, similar to a hormone, and thus there are setnew research directions o f  cystatins as 
markers o f  diseases, including the ones causing oromaxillofacial pain,prosopalgia, and the 
monitoring o f disease’s evolution and o f treatment efficiency.
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Introduction: The fundamental process involved in audition is controlled by hundreds o f  
genes, 69 o f which are known: 24 AD, 40 AR, 2XL, 3 mitochondrial. M utant alleles o f  these genes 
may determine hereditary deafness. Loss o f  hearing is etiologically heterogeneous, 2/3 o f  childhood 
onset deafness being o f  a genetic cause. The prevalence o f bilateral sensoneural deafness (>40 dB) 
is 1:500 healthy new-borns. More than 50% o f  prelingual deafness is o f  genetic origin, 70% o f  
which is nonsyndromic, from which 85% is autosomal-recessive. About 400 syndromes include 
deafness as a component o f  its phenotype. In Republic o f  Moldova, deafness hold 3rd place in the 
structure o f disability, number o f hearing impaired children being more than 2000.
Purpose and objectives: Analysis o f molecular-genetic aspects o f  deafness and subsequent 
implications. Objectives were defined as: (1) systematic review o f  scientific literature regarding 
epidemiology, genetic heterogeneity, diagnosis and consequences o f  hereditary deafness; (2) 
analysis o f deafness incidence in Republic o f Moldova; (3) elucidating critically the practical 
implications regarding genotype variations o f hereditary deafness.
Materials and methods: The study group was prospectively selected during 2013/14, from 
deaf patients at Republican Center of Audiology. Patients filled up a questionnaire at discharge. 
Additionally to cases (patients with hereditary deafness), were random selected an equal number o f  
controls (patients wdth non-hereditary deafness).
Results: The study group consisted o f 10 cases and 10 controls, with a mean age o f 5±2,22 years, 
65% females. Mean age o f diagnosis was 2,3±1,49 years, being fit into maximal plasticity period o f  
central auditory pathways. The count o f sensoneural deafness in hereditary group represented 90%, with a 
single case o f transmission hearing loss, bilateral in 90% o f cases and 10% o f controls, with a postlingual 
onset in 70%. Pedigree analysis o f cases showed 90% AR transmission pattern, and 10% AD.
Conclusion: (1) The cause o f deafness may be clinically suspected due to anamnesis and 
syndrome association, but substrate confirmation should be done with molecular-genetic tests. 
Although family history can help suspect the genetic cause o f  deafness, absence o f  hearing-loss 
anamnesis at family members does not mean that hearing impairment is not o f  genetic origin. (2) 
Recognition o f genetic heterogeneity is important in clinical diagnosis, prognosis and genetic 
counseling regarding recurrence risk.
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